PDZD8 is a novel gag-interacting factor that promotes retroviral infection

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8990-8995

  Henning, Matthew S ^a   Morham, Scott G ^b   Goff, Stephen P ^c   Naghavi, Mojgan H ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b Myriad Pharmaceuticals   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PDZD8 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; CARRIER PROTEIN; PDZD8 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPRECIPITATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; REVERSE TRANSCRIPTION; TWO HYBRID SYSTEM; VIRUS ENTRY; CELL LINE; CHEMISTRY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; PDZ DOMAIN; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CARRIER PROTEINS; CELL LINE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HUMANS; PDZ DOMAINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 77956636731     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00843-10     Document Type: Article

References (44)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Bieniasz, P. D. 2004. Intrinsic immunity: a front-line defense against viral attack. Nat. Immunol. 5:1109-1115.
3. Blot, V., L. Delamarre, F. Perugi, D. Pham, S. Benichou, R. Benarous, T. Hanada, A. H. Chishti, M. C. Dokhelar, and C. Pique. 2004. Human Dlg protein binds to the envelope glycoproteins of human T-cell leukemia virus type 1 and regulates envelope mediated cell-cell fusion in T lymphocytes. J. Cell Sci. 117:3983-3993.
4. Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
5. Brass, A. L., D. M. Dykxhoorn, Y. Benita, N. Yan, A. Engelman, R. J. Xavier, J. Lieberman, and S. J. Elledge. 2008. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319:921-926.
6. Bukrinskaya, A., B. Brichacek, A. Mann, and M. Stevenson. 1998. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188: 2113-2125.
7. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
8. Chu, H., J. J. Wang, and P. Spearman. 2009. Human immunodeficiency virus type-1 gag and host vesicular trafficking pathways. Curr. Top. Microbiol. Immunol. 339:67-84.
9. Crawford, S., and S. P. Goff. 1984. Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J. Virol. 49:909-917.
10. Diaz-Griffero, F., N. Vandegraaff, Y. Li, K. McGee-Estrada, M. Stremlau, S. Welikala, Z. Si, A. Engelman, and J. Sodroski. 2006. Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. Virology 351:404-419.
11. Dong, X., H. Li, A. Derdowski, L. Ding, A. Burnett, X. Chen, T. R. Peters, T. S. Dermody, E. Woodruff, J. J. Wang, and P. Spearman. 2005. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120:663-674.
12. Feng, W., and M. Zhang. 2009. Organization and dynamics of PDZ-domain-related supramodules in the postsynaptic density. Nat. Rev. Neurosci. 10: 87-99.
13. Garrus, J. E., U. K. von Schwedler, O. W. Pornillos, S. G. Morham, K. H. Zavitz, H. E. Wang, D. A. Wettstein, K. M. Stray, M. Cote, R. L. Rich, D. G. Myszka, and W. I. Sundquist. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65.
14. Goff, S. P. 2007. Host factors exploited by retroviruses. Nat. Rev. Microbiol. 5:253-263.
15. Gonzalez-Scarano, F., and J. Martin-Garcia. 2005. The neuropathogenesis of AIDS. Nat. Rev. Immunol. 5:69-81.
16. Haedicke, J., C. Brown, and M. H. Naghavi. 2009. The brain-specific factor FEZ1 is a determinant of neuronal susceptibility to HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 106:14040-14045.
17. Haedicke, J., K. de Los Santos, S. P. Goff, and M. H. Naghavi. 2008. The ezrin-radixin-moesin family member ezrin regulates stable microtubule formation and retroviral infection. J. Virol. 82:4665-4670.
18. Harris, B. Z., and W. A. Lim. 2001. Mechanism and role of PDZ domains in signaling complex assembly. J. Cell Sci. 114:3219-3231.
19. Janabi, N., S. Peudenier, B. Heron, K. H. Ng, and M. Tardieu. 1995. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci. Lett. 195:105-108.
20. Javanbakht, H., F. Diaz-Griffero, W. Yuan, D. F. Yeung, X. Li, B. Song, and J. Sodroski. 2007. The ability of multimerized cyclophilin A to restrict retrovirus infection. Virology 367:19-29.
21. Javier, R. T. 2008. Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene 27:7031-7046.
22. Kennedy, M. B. 1995. Origin of PDZ (DHR, GLGF) domains. Trends Biochem. Sci. 20:350.
23. Kiernan, R. E., A. Ono, G. Englund, and E. O. Freed. 1998. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72:4116-4126.
24. Konig, R., Y. Zhou, D. Elleder, T. L. Diamond, G. M. Bonamy, J. T. Irelan, C. Y. Chiang, B. P. Tu, P. D. De Jesus, C. E. Lilley, S. Seidel, A. M. Opaluch, J. S. Caldwell, M. D. Weitzman, K. L. Kuhen, S. Bandyopadhyay, T. Ideker, A. P. Orth, L. J. Miraglia, F. D. Bushman, J. A. Young, and S. K. Chanda. 2008. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135:49-60.
25. Kumar, P. P., P. K. Purbey, D. S. Ravi, D. Mitra, and S. Galande. 2005. Displacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells. Mol. Cell. Biol. 25:1620-1633.
26. Leung, J., A. Yueh, F. S. Appah, Jr., B. Yuan, K. de los Santos, and S. P. Goff. 2006. Interaction of Moloney murine leukemia virus matrix protein with IQGAP. EMBO J. 25:2155-2166.
27. Luttge, B. G., and E. O. Freed. 2010. FIV Gag: virus assembly and host-cell interactions. Vet. Immunol. Immunopathol. 134:3-13.
28. Masoudi, A. A., K. Uchida, K. Yokouchi, K. Ohwada, A. R. Abbasi, T. Tsuji, T. Watanabe, T. Hirano, Y. Sugimoto, and T. Kunieda. 2008. Linkage mapping of the locus responsible for forelimb-girdle muscular anomaly of Japanese black cattle on bovine chromosome 26. Anim. Genet. 39:46-50.
29. Naghavi, M. H., T. Hatziioannou, G. Gao, and S. P. Goff. 2005. Overexpression of fasciculation and elongation protein zeta-1 (FEZ1) induces a postentry block to retroviruses in cultured cells. Genes Dev. 19:1105-1115.
30. Naghavi, M. H., S. Valente, T. Hatziioannou, K. de Los Santos, Y. Wen, C. Mott, G. G. Gundersen, and S. P. Goff. 2007. Moesin regulates stable microtubule formation and limits retroviral infection in cultured cells. EMBO J. 26:41-52.
31. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
32. Perugi, F., D. Muriaux, B. C. Ramirez, S. Chabani, E. Decroly, J. L. Darlix, V. Blot, and C. Pique. 2009. Human Discs Large is a new negative regulator of human immunodeficiency virus-1 infectivity. Mol. Biol. Cell 20:498-508.
33. Sheng, M., and C. Sala. 2001. PDZ domains and the organization of supramolecular complexes. Annu. Rev. Neurosci. 24:1-29.
34. Sokolskaja, E., and J. Luban. 2006. Cyclophilin, TRIM5, and innate immunity to HIV-1. Curr. Opin. Microbiol. 9:404-408.
35. Tang, S., T. Murakami, B. E. Agresta, S. Campbell, E. O. Freed, and J. G. Levin. 2001. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 75:9357-9366.
36. Thomas, M., N. Narayan, D. Pim, V. Tomaic, P. Massimi, K. Nagasaka, C. Kranjec, N. Gammoh, and L. Banks. 2008. Human papillomaviruses, cervical cancer and cell polarity. Oncogene 27:7018-7030.
37. Toohey, K., K. Wehrly, J. Nishio, S. Perryman, and B. Chesebro. 1995. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread. Virology 213: 70-79.
38. Walsh, D., and I. Mohr. 2004. Phosphorylation of eIF4E by Mnk-1 enhances HSV-1 translation and replication in quiescent cells. Genes Dev. 18:660-672.
39. Wehrly, K., and B. Chesebro. 1997. p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents. Methods 12:288-293.
40. Wolf, D., and S. P. Goff. 2008. Host restriction factors blocking retroviral replication. Annu. Rev. Genet. 42:143-163.
41. Yee, J. K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 91:9564-9568.
42. Yeung, M. L., L. Houzet, V. S. Yedavalli, and K. T. Jeang. 2009. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J. Biol. Chem. 284:19463-19473.
43. Yu, Q., D. Chen, R. Konig, R. Mariani, D. Unutmaz, and N. R. Landau. 2004. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication. J. Biol. Chem. 279:53379-53386.
44. Zhou, H., M. Xu, Q. Huang, A. T. Gates, X. D. Zhang, J. C. Castle, E. Stec, M. Ferrer, B. Strulovici, D. J. Hazuda, and A. S. Espeseth. 2008. Genomescale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4:495-504.